Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Resource Center: Diabetes

By Anne Harding NEW YORK (Reuters Health) – Allopurinol reduces left ventricular hypertrophy (LVH) in type 2 diabetics with well-controlled blood pressure, new findings show. From 40% to 70% of type 2 diabetics have LVH, which independently...
By Ben Hirschler AMSTERDAM (Reuters) – The dipeptidyl peptidase 4 (DPP-4) class of drugs got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure. Reassuringly, the...
NEW YORK (Reuters Health) – The dipeptidyl peptidase-4 (DPP4) inhibitor linagliptin was safe and effective for lowering glycated hemoglobin (HbA1c) in a controlled trial of elderly patients with poorly controlled type 2 diabetes. Studies of...
123